| Understanding TERT promoter mutations: a common path to immortality RJA Bell, HT Rube, A Xavier-Magalhães, BM Costa, A Mancini, JS Song, ... Molecular Cancer Research 14 (4), 315-323, 2016 | 284 | 2016 |
| Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma BM Costa, JS Smith, Y Chen, J Chen, HS Phillips, KD Aldape, G Zardo, ... Cancer research 70 (2), 453-462, 2010 | 165 | 2010 |
| Disruption of the β1L isoform of GABP reverses glioblastoma replicative immortality in a TERT promoter mutation-dependent manner A Mancini, A Xavier-Magalhaes, WS Woods, KT Nguyen, AM Amen, ... Cancer cell 34 (3), 513-528. e8, 2018 | 120 | 2018 |
| Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities AJ Salgado, JC Sousa, BM Costa, AO Pires, A Mateus-Pinheiro, ... Frontiers in cellular neuroscience 9, 249, 2015 | 119 | 2015 |
| Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas V Miranda-Gonçalves, S Granja, O Martinho, M Honavar, M Pojo, ... Oncotarget 7 (29), 46335, 2016 | 111 | 2016 |
| Association between functional EGF+ 61 polymorphism and glioma risk BM Costa, P Ferreira, S Costa, P Canedo, P Oliveira, A Silva, F Pardal, ... Clinical cancer research 13 (9), 2621-2626, 2007 | 103 | 2007 |
| MicroRNA-375 plays a dual role in prostate carcinogenesis P Costa-Pinheiro, J Ramalho-Carvalho, FQ Vieira, J Torres-Ferreira, ... Clinical epigenetics 7, 1-14, 2015 | 102 | 2015 |
| Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma N Butowski, SM Chang, KR Lamborn, MY Polley, R Pieper, JF Costello, ... Neuro-oncology 13 (12), 1331-1338, 2011 | 87 | 2011 |
| Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study BM Costa, C Caeiro, I Guimarães, O Martinho, T Jaraquemada, I Augusto, ... Oncology reports 23 (6), 1655-1662, 2010 | 80 | 2010 |
| Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids AJ Rodrigues, P Leão, JM Pêgo, D Cardona, MM Carvalho, M Oliveira, ... Molecular psychiatry 17 (12), 1295-1305, 2012 | 68 | 2012 |
| Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication AS Pires-Luís, M Vieira-Coimbra, FQ Vieira, P Costa-Pinheiro, ... Epigenetics 10 (11), 1033-1043, 2015 | 63 | 2015 |
| A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide M Pojo, CS Gonçalves, A Xavier-Magalhães, AI Oliveira, T Gonçalves, ... Oncotarget 6 (10), 7657, 2015 | 58 | 2015 |
| Loss of caveolin-1 in metastasis-associated macrophages drives lung metastatic growth through increased angiogenesis W Celus, G Di Conza, AI Oliveira, M Ehling, BM Costa, M Wenes, ... Cell reports 21 (10), 2842-2854, 2017 | 57 | 2017 |
| Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer D Almeida-Rios, I Graça, FQ Vieira, J Ramalho-Carvalho, E Pereira-Silva, ... Oncotarget 7 (33), 53018, 2016 | 52 | 2016 |
| Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome BM Costa, M Viana-Pereira, R Fernandes, S Costa, P Linhares, R Vaz, ... Cancer epidemiology, biomarkers & prevention 20 (12), 2610-2617, 2011 | 52 | 2011 |
| Crosstalk between glial and glioblastoma cells triggers the “go-or-grow” phenotype of tumor cells AI Oliveira, SI Anjo, J Vieira de Castro, SC Serra, AJ Salgado, B Manadas, ... Cell Communication and Signaling 15, 1-12, 2017 | 51 | 2017 |
| A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97 J Ramalho-Carvalho, CS Gonçalves, I Graça, D Bidarra, E Pereira-Silva, ... Clinical epigenetics 10, 1-15, 2018 | 48 | 2018 |
| Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology J Vieira de Castro, ED Gomes, S Granja, SI Anjo, F Baltazar, B Manadas, ... Journal of Translational Medicine 15, 1-14, 2017 | 46 | 2017 |
| MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples G Outeiro-Pinho, D Barros-Silva, E Aznar, AI Sousa, M Vieira-Coimbra, ... Journal of Experimental & Clinical Cancer Research 39, 1-11, 2020 | 43 | 2020 |
| Glioblastoma: is there any blood biomarker with true clinical relevance? P Linhares, B Carvalho, R Vaz, BM Costa International journal of molecular sciences 21 (16), 5809, 2020 | 42 | 2020 |
